AMLX
Price
$20.31
Change
-$0.44 (-2.12%)
Updated
Jul 31 closing price
Capitalization
2.26B
3 days until earnings call
Intraday BUY SELL Signals
HROW
Price
$38.77
Change
-$0.17 (-0.44%)
Updated
Jul 31 closing price
Capitalization
1.45B
8 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

AMLX vs HROW

AMLX vs HROW Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
AMLX vs. HROW commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AMLX is a Buy and HROW is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 03, 2026
Stock price -- (AMLX: $20.31 vs. HROW: $38.77)
Brand notoriety: AMLX and HROW are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: AMLX: 80% vs. HROW: 23%
Market capitalization -- AMLX: $2.26B vs. HROW: $1.45B
AMLX [@Pharmaceuticals: Generic] is valued at $2.26B. HROW’s [@Pharmaceuticals: Generic] market capitalization is $1.45B. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $63.66B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $4.1B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AMLX’s FA Score shows that 0 FA rating(s) are green whileHROW’s FA Score has 1 green FA rating(s).

  • AMLX’s FA Score: 0 green, 5 red.
  • HROW’s FA Score: 1 green, 4 red.
According to our system of comparison, AMLX is a better buy in the long-term than HROW.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AMLX’s TA Score shows that 5 TA indicator(s) are bullish while HROW’s TA Score has 4 bullish TA indicator(s).

  • AMLX’s TA Score: 5 bullish, 4 bearish.
  • HROW’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, AMLX is a better buy in the short-term than HROW.

Price Growth

AMLX (@Pharmaceuticals: Generic) experienced а +10.32% price change this week, while HROW (@Pharmaceuticals: Generic) price change was +0.83% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +1.61%. For the same industry, the average monthly price growth was -5.02%, and the average quarterly price growth was +19.02%.

Reported Earning Dates

AMLX is expected to report earnings on Aug 06, 2026.

HROW is expected to report earnings on Aug 11, 2026.

Industries' Descriptions

@Pharmaceuticals: Generic (+1.61% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AMLX($2.26B) has a higher market cap than HROW($1.45B). AMLX YTD gains are higher at: 68.129 vs. HROW (-20.878). HROW has higher annual earnings (EBITDA): 32.5M vs. AMLX (-158.8M). AMLX has more cash in the bank: 280M vs. HROW (94.6M). AMLX has less debt than HROW: AMLX (5.63M) vs HROW (301M). HROW has higher revenues than AMLX: HROW (269M) vs AMLX (0).
AMLXHROWAMLX / HROW
Capitalization2.26B1.45B156%
EBITDA-158.8M32.5M-489%
Gain YTD68.129-20.878-326%
P/E Ratio2.69N/A-
Revenue0269M-
Total Cash280M94.6M296%
Total Debt5.63M301M2%
FUNDAMENTALS RATINGS
HROW: Fundamental Ratings
HROW
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
73
Overvalued
PROFIT vs RISK RATING
1..100
54
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
59
P/E GROWTH RATING
1..100
11
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
AMLXHROW
RSI
ODDS (%)
Bearish Trend 4 days ago
78%
Bearish Trend 4 days ago
80%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
79%
Bullish Trend 4 days ago
83%
Momentum
ODDS (%)
Bullish Trend 4 days ago
79%
Bearish Trend 4 days ago
80%
MACD
ODDS (%)
Bullish Trend 4 days ago
88%
Bearish Trend 4 days ago
83%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
82%
Bullish Trend 4 days ago
81%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
84%
Bearish Trend 4 days ago
81%
Advances
ODDS (%)
Bullish Trend 5 days ago
80%
Bullish Trend 18 days ago
84%
Declines
ODDS (%)
Bearish Trend 12 days ago
81%
Bearish Trend 8 days ago
78%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
79%
Bullish Trend 4 days ago
76%
Aroon
ODDS (%)
Bullish Trend 4 days ago
89%
Bullish Trend 4 days ago
85%
View a ticker or compare two or three
Interact to see
Advertisement
AMLX
Daily Signal:
Gain/Loss:
HROW
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
ORCX17.540.61
+3.60%
Defiance Daily Target 2X Long ORCL ETF
TCHI23.240.38
+1.68%
iShares MSCI China Multisector Tech ETF
PCR18.740.01
+0.06%
Simplify VettaFi Private Credit Stgy ETF
RZV148.58-0.28
-0.19%
Invesco S&P SmallCap 600® Pure Value ETF
GAB5.61-0.04
-0.71%
Gabelli Equity Trust (The)

AMLX and

Correlation & Price change

A.I.dvisor indicates that over the last year, AMLX has been loosely correlated with OCUL. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if AMLX jumps, then OCUL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AMLX
1D Price
Change %
AMLX100%
-2.12%
OCUL - AMLX
46%
Loosely correlated
-3.54%
LRMR - AMLX
45%
Loosely correlated
-0.13%
JAZZ - AMLX
43%
Loosely correlated
-2.14%
RGNX - AMLX
43%
Loosely correlated
-4.25%
IDYA - AMLX
43%
Loosely correlated
-2.47%
More

HROW and

Correlation & Price change

A.I.dvisor tells us that HROW and AMLX have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that HROW and AMLX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HROW
1D Price
Change %
HROW100%
-0.44%
AMLX - HROW
31%
Poorly correlated
-2.12%
AMRX - HROW
30%
Poorly correlated
-0.97%
AQST - HROW
30%
Poorly correlated
-0.67%
RMTI - HROW
27%
Poorly correlated
+1.27%
SIGA - HROW
26%
Poorly correlated
+0.62%
More